Insider Transactions Reported by 23 Insiders of Traws Pharma, Inc.

Symbol
TRAW on Nasdaq
Location
Newtown, PA

There are no Buy or Sell transactions made by insiders since 22 Jan 2025

Traws Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Viriom, Inc. 10%+ Owner $1,480,590 03 Apr 2024
Iain Dukes Chief Executive Officer, Director $438,092 12 Dec 2025
Nikolay Savchuk Chief Operating Officer, Director $385,551 12 Dec 2025
Charles David Pauza Chief Science Officer Virology $296,885 12 Dec 2025
Robert Redfield Chief Medical Officer $291,632 12 Dec 2025
ORBIMED ADVISORS LLC 10%+ Owner $282,940 29 Dec 2024
Werner Cautreels Director $279,608 12 Dec 2025
Steven M. Fruchtman PRESIDENT, CHIEF EXECUTIVE OFF, Director $98,282 13 Mar 2024
ABRAHAM N. OLER SVP Corp Dev & Gen Counsel $36,818 07 Feb 2022
Mark S. Gelder MD Chief Medical Officer $24,544 13 Mar 2023
Mark Patrick Guerin Chief Financial Officer $23,400 05 Feb 2025
Mary Teresa Shoemaker Director $16,107 12 Dec 2025
JACK E. STOVER Director $15,782 12 Dec 2025
Trafford Clarke Director $15,761 12 Dec 2025
John Leaman Director $10,388 12 Dec 2025
TPAV, LLC 10%+ Owner $0 02 Apr 2025
Victor M. Moyo Chief Medical Officer 02 Oct 2023
JEROME GROOPMAN Director 10 Aug 2023
JAMES J. MARINO Director 10 Aug 2023
VIREN MEHTA Director 10 Aug 2023
Peter Atadja Director 10 Aug 2023
Nora Brennan Interim CFO 05 Feb 2025
Luba Greenwood Director 16 Sep 2024

Recent Insider Transactions by Companies or Individuals for Traws Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.